Literature DB >> 22823858

Moderators and non-specific predictors of treatment outcome for anxiety disorders: a comparison of cognitive behavioral therapy to acceptance and commitment therapy.

Kate B Wolitzky-Taylor1, Joanna J Arch, David Rosenfield, Michelle G Craske.   

Abstract

OBJECTIVE: Understanding for whom, and under what conditions, treatments exert their greatest effects is essential for developing personalized medicine. Research investigating moderators of outcome among evidence-based treatments for anxiety disorders is lacking. The current study examined several theory-driven and atheoretical putative moderators of outcome in cognitive behavioral therapy (CBT) and acceptance and commitment therapy (ACT).
METHOD: Eighty-seven patients with a Diagnostic and Statistical Manual of Mental Disorders (4th ed., text rev.; DSM-IV-TR; American Psychiatric Association, 2000) anxiety disorder completed 12 sessions of ACT or CBT and were assessed with a self-report measure of anxiety at baseline, post-treatment, and 6- and 12-month follow-up assessments.
RESULTS: CBT outperformed ACT among those at moderate levels of baseline anxiety sensitivity, and among those with no comorbid mood disorder. ACT outperformed CBT among those with comorbid mood disorders. Higher baseline neuroticism was associated with poorer outcome across treatment conditions. Neither moderation nor general prediction was observed for baseline anxiety disorder comorbidity, race/ethnicity, gender, age, or baseline severity of the principal anxiety disorder. When including all randomized participants who completed the pre-treatment assessment (N = 121), a similar pattern was observed.
CONCLUSIONS: Prescriptive recommendations for clinical practice and directions for future research are discussed. (PsycINFO Database Record (c) 2012 APA, all rights reserved).

Entities:  

Mesh:

Year:  2012        PMID: 22823858     DOI: 10.1037/a0029418

Source DB:  PubMed          Journal:  J Consult Clin Psychol        ISSN: 0022-006X


  33 in total

1.  The role of gender in moderating treatment outcome in collaborative care for anxiety.

Authors:  Kathleen M Grubbs; Ann M Cheney; John C Fortney; Carrie Edlund; Xiaotong Han; Patricia Dubbert; Cathy D Sherbourne; Michelle G Craske; Murray B Stein; Peter P Roy-Byrne; J Greer Sullivan
Journal:  Psychiatr Serv       Date:  2014-12-15       Impact factor: 3.084

2.  Baseline patterns of substance use disorder severity and depression and anxiety symptoms moderate the efficacy of mindfulness-based relapse prevention.

Authors:  Corey R Roos; Sarah Bowen; Katie Witkiewitz
Journal:  J Consult Clin Psychol       Date:  2017-11

Review 3.  The role of emotion and emotion regulation in social anxiety disorder.

Authors:  Hooria Jazaieri; Amanda S Morrison; Philippe R Goldin; James J Gross
Journal:  Curr Psychiatry Rep       Date:  2015-01       Impact factor: 5.285

4.  Prognostic subgroups for remission and response in the Coordinated Anxiety Learning and Management (CALM) trial.

Authors:  J MacLaren Kelly; Ewgeni Jakubovski; Michael H Bloch
Journal:  J Clin Psychiatry       Date:  2015-03       Impact factor: 4.384

5.  The Future of Intervention Science: Process-Based Therapy.

Authors:  Stefan G Hofmann; Steven C Hayes
Journal:  Clin Psychol Sci       Date:  2018-05-29

6.  The third wave of cognitive behavioral therapy and the rise of process-based care.

Authors:  Steven C Hayes; Stefan G Hofmann
Journal:  World Psychiatry       Date:  2017-10       Impact factor: 49.548

7.  Guided Self-Help Works: Randomized Waitlist Controlled Trial of Pacifica, a Mobile App Integrating Cognitive Behavioral Therapy and Mindfulness for Stress, Anxiety, and Depression.

Authors:  Christine Moberg; Andrea Niles; Dale Beermann
Journal:  J Med Internet Res       Date:  2019-06-08       Impact factor: 5.428

8.  An examination of the bidirectional relationship between functioning and symptom levels in patients with anxiety disorders in the CALM study.

Authors:  L A Brown; J L Krull; P Roy-Byrne; C D Sherbourne; M B Stein; G Sullivan; R D Rose; A Bystritsky; M G Craske
Journal:  Psychol Med       Date:  2014-10-02       Impact factor: 7.723

9.  Randomized controlled trial of cognitive behavioral therapy and acceptance and commitment therapy for social phobia: outcomes and moderators.

Authors:  Michelle G Craske; Andrea N Niles; Lisa J Burklund; Kate B Wolitzky-Taylor; Jennifer C Plumb Vilardaga; Joanna J Arch; Darby E Saxbe; Matthew D Lieberman
Journal:  J Consult Clin Psychol       Date:  2014-07-07

10.  Attentional bias and emotional reactivity as predictors and moderators of behavioral treatment for social phobia.

Authors:  Andrea N Niles; Bita Mesri; Lisa J Burklund; Matthew D Lieberman; Michelle G Craske
Journal:  Behav Res Ther       Date:  2013-07-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.